Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guadalupe Rodriguez

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Annals of Internal Medicine|March 24, 2020
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized TrialEmanuele Angelucci, Junmin Li, Peter Greenberg, et al.
Expert Opinion on Drug Safety|January 13, 2018
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort studyEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen-Guadalupe Rodriguez-Gonzalez, et al.
Health Informatics Journal|January 9, 2020
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safetyMBelén Marzal-Alfaro, Carmen Guadalupe Rodriguez-Gonzalez, Vicente Escudero-Vilaplana, et al.
Plos Pathogens|October 13, 2017
Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patientsJasmina Vasilijevic, Noelia Zamarreño, Juan Carlos Oliveros, et al.
Frontiers in Medicine|April 26, 2021
Frequency and Risk Factors for Spontaneous Pneumomediastinum in COVID-19 PatientsTania Guadalupe Rodriguez-Arciniega, Erick Sierra-Diaz, Jesus Armando Flores-Martinez, et al.
Aging Cell|May 26, 2026
Loss of Brain-Derived Estrogen Is Associated With Sex- and Age-Dependent Alterations in Memory, Affective Behavior, and Hippocampal Extracellular Matrix Gene ExpressionNatalie C Piehl, Ariel W Halle, Guadalupe Rodriguez, et al.
British Journal of Haematology|February 12, 2024
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO studyMatteo Sarocchi, Junmin Li, Xiao Li, et al.
The Annals of Pharmacotherapy|July 17, 2016
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical PracticeEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen Guadalupe Rodriguez-Gonzalez, et al.
International Journal of Antimicrobial Agents|December 1, 2020
COVID-19 in hospitalised patients in Spain: a cohort study in MadridCarmen Guadalupe Rodriguez-Gonzalez, Esther Chamorro-de-Vega, Maricela Valerio, et al.
Expert Review of Clinical Pharmacology|January 27, 2021
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in SpainEsther Chamorro-de-Vega, Carmen-Guadalupe Rodriguez-Gonzalez, Silvia Manrique-Rodríguez, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Annals of Internal Medicine|March 24, 2020
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized TrialEmanuele Angelucci, Junmin Li, Peter Greenberg, et al.
Expert Opinion on Drug Safety|January 13, 2018
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort studyEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen-Guadalupe Rodriguez-Gonzalez, et al.
Health Informatics Journal|January 9, 2020
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safetyMBelén Marzal-Alfaro, Carmen Guadalupe Rodriguez-Gonzalez, Vicente Escudero-Vilaplana, et al.
Plos Pathogens|October 13, 2017
Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patientsJasmina Vasilijevic, Noelia Zamarreño, Juan Carlos Oliveros, et al.
Frontiers in Medicine|April 26, 2021
Frequency and Risk Factors for Spontaneous Pneumomediastinum in COVID-19 PatientsTania Guadalupe Rodriguez-Arciniega, Erick Sierra-Diaz, Jesus Armando Flores-Martinez, et al.
Aging Cell|May 26, 2026
Loss of Brain-Derived Estrogen Is Associated With Sex- and Age-Dependent Alterations in Memory, Affective Behavior, and Hippocampal Extracellular Matrix Gene ExpressionNatalie C Piehl, Ariel W Halle, Guadalupe Rodriguez, et al.
British Journal of Haematology|February 12, 2024
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO studyMatteo Sarocchi, Junmin Li, Xiao Li, et al.
The Annals of Pharmacotherapy|July 17, 2016
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical PracticeEsther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen Guadalupe Rodriguez-Gonzalez, et al.
International Journal of Antimicrobial Agents|December 1, 2020
COVID-19 in hospitalised patients in Spain: a cohort study in MadridCarmen Guadalupe Rodriguez-Gonzalez, Esther Chamorro-de-Vega, Maricela Valerio, et al.
Expert Review of Clinical Pharmacology|January 27, 2021
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in SpainEsther Chamorro-de-Vega, Carmen-Guadalupe Rodriguez-Gonzalez, Silvia Manrique-Rodríguez, et al.
Pageof 6